Menu
We developed this site to share research to further the knowledge and understanding of controlled substances’ impact on the Canadian population. Applying innovative research methods, we try to understand social and behavioral patterns of tobacco, alcohol, cannabis, and other health-related substances.
Once we identify the models, we develop strategies to change them and support vulnerable groups, including low-income or pregnant individuals, to have critical information to make informed choices concerning using substances or vaping.
Finally, we utilize our discoveries to support the scientific community and determine if there are social or policy-level changes that can help population-level changes that improve the well-being of society.
Dr. Daniel Corsi is a Scientist at CHEO Research Institute and an Epidemiologist with BORN Ontario. He is also an Assistant Professor at the University of Ottawa Department of Obstetrics and Gynecology with the School of Epidemiology and Public Health.
As an epidemiologist, Daniel focuses on maternal substance use in pregnancy. His research uses innovative methods to understand the influence of socioeconomic status and substance use on maternal child health.
Daniel received his Ph.D. in Population and Public Health in 2012 from McMaster University and completed his postdoctoral training at the Harvard Center for Population and Development Studies in 2014. He is currently the principal investigator on a CIHR-funded project exploring the long-term development of children prenatally exposed to cannabis.
In this field of research, Daniel’s scholarly contributions include over $2.4M in CIHR funding as a principal investigator, 130 peer-reviewed articles, and mentoring more thant thirty scholars, from graduates to postdoctoral fellows.
As a demographer and sociologist, Adam focuses on research related to population health disparities and the community-mediated causes of poor health.
He received his Ph.D. in Demography and Sociology in 2013 from Pennsylvania State University and completed his postdoctoral training at the Harvard Center for Population and Development Studies in 2015. Adam researches the relationship between behavioral health and community socioeconomic hardships, using statistical methods to identify disproportionately impacted locales and policies to restore health equity. His research contributions include over thirty scientific publications and a grant portfolio exceeding $350,000.
Outside of academia, Adam’s research insights have influenced health policy in the United States, including the guidance outlined by the Food and Drug Administration and the US Surgeon General on nicotine regulations.
As a professor, Adam teaches courses in demographic techniques, health disparities, and quantitative methods.